Jennifer Griffin, MD, MPH Dept. of Obstetrics and Gynecology

Similar documents
Nicole Kounalakis, MD

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

Common Breast Complaints:

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer

D. FREQUENTLY ASKED QUESTIONS

OBJECTIVES By the end of this segment, the community participant will be able to:

Non-cancerous Breast Conditions

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

CRICO Breast Care Management Algorithm

APGO Clinical Skills Curriculum. The Breast Exam

Infrared Thermography Not a Useful Breast Cancer Screening Tool

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES

Provider Reimbursement for Women's Cancer Screening Program

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

Breast Cancer Screening. Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW

Breast Ultrasound: Benign vs. Malignant Lesions

Breast Cancer. Presentation by Dr Mafunga

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Breast Cancer Screening

Alaska Breast & Cervical Health Partnership. Healthy Women, Healthy Alaska Through Early Detection

Mammography. What is Mammography?

Mammography AND CLINICAL BREAST EXAMS. joytolife.org WHAT YOU SHOULD KNOW ABOUT BREAST CANCER HOW TO DO A BREAST SELF-EXAM EARLY DETECTION SAVES LIVES

A Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer

VI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS

Feeling Your Way To Healthy Breast. Lisa Barnes, BSN, RN Ruth Fay,B.A.,M.B.A.,RN Mary Grady, BSN, RN Margaret Richmond, MA, RN

MAMMOGRAPHY GOALS AND OBJECTIVES

Ductal carcinoma in situ (DCIS)

Understanding. Breast Changes. National Cancer Institute. A Health Guide for Women. National Institutes of Health

Men s Health: Testicular & Breast. September 2012

PART TWO: DIAGNOSING BREAST CANCER

BREAST IMAGING. Developed by the Ad Hoc Committee on Resident and Fellow Education of the Society of Breast Imaging

Management of Common Breast Problems

FRIEND TO FRIEND CPT CODES Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

Guide to Understanding Breast Cancer

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer

The best treatment Your guide to breast cancer treatment in Scotland

Florida Breast Health Specialists Breast Cancer Information and Facts

Understanding Your Risk of Ovarian Cancer

Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics

Ovarian Cyst. Homoeopathy Clinic. Introduction. Types of Ovarian Cysts. Contents. Case Reports. 21 August 2002

Breast Pain. National Cancer Helpline

Medicare Part B. Mammograms - Updated Billing Guide for Screening and Diagnostic Tests

Official reprint from UpToDate UpToDate

Your Protection Starts with Breast Cancer Early Screening

Ovarian cysts Diagnosis and Management

Reduce Your Risk of Breast Cancer

Breast Density Legislation: Implications for primary care providers

The best treatment Your guide to breast cancer treatment in England and Wales

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

Office Visits. Breast

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Stereotactic Breast Biopsy

Recommendations for cross-sectional imaging in cancer management, Second edition

Mammograms & Breast Health. An Information Guide for Women U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention

GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP

Breast Sonography general goal. Optimizing Breast Sonography. BUS indications -- all. Breast Sonography specific goals.

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL

Epidemiology. Breast Cancer Screening, Diagnosis, Biology and Long-Term Follow-Up EDUCATIONAL OBJECTIVES

Office of Population Health Genomics

OVARIAN CYSTS. Types of Ovarian Cysts There are many types of ovarian cysts and these can be categorized into functional and nonfunctional

BREAST HEALTH HISTORY FORM

Breast Cancer Prevention and Early Detection

Sustaining a High-Quality Breast MRI Practice

Are You at Risk for Ovarian Cancer?

Breast Cancer: Early Detection

dedicated to curing BREAST CANCER

BreastScreen and You. Information about mammographic screening

Breast Cancer Screening

BREAST CANCER PATHOLOGY

Frequently Asked Questions About Ovarian Cancer

What is DCIS? Contents. The breasts

Breast Cancer Awareness Month

Mammography Education, Inc.

Breast Cancer: Early Detection

Sage Screening Program. Provider Manual

Participate in Cancer Screening

Breast Cancer Diagnostic Algorithms

CMS Limitations Guide Mammograms and Bone Density Radiology Services

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Breast cancer in the family

Goiter. This reference summary explains goiters. It covers symptoms and causes of the condition, as well as treatment options.

Ovarian Cancer Genetic Testing: Why, When, How?


The Diagnosis of Cancer in the Pathology Laboratory

What You Need to Know Before Treatment About: Breast Cancer

Breast Health Starts Here

Breast Cancer Prevention and Early Detection

SOUTH EAST LONDON CANCER NETWORK BREAST TUMOUR WORKING GROUP GUIDELINES

Areola: The area of dark-colored skin on the breast that surrounds the nipple.

Harlem Hospital Center Integrated Radiology Residency Program Mammography Educational goals and objectives

Common Breast Problems

Breast Cancer Understanding your diagnosis

Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.

Transcription:

Jennifer Griffin, MD, MPH Dept. of Obstetrics and Gynecology

16% of women ages 40-69 sought advice from a physician related to a breast complaint. 23 visits per 1000 woman years. Wide range of physicians may encounter breast complaints, but few experts.

Most common malignancy 2 nd leading cause of cancer death US: 1 in 8 lifetime risk (12.5%)

Breast cancer identified in 11% of patients with lump, and 4% of women with any complaint. Between 50-70% of breast cancers are detected based on symptoms not by screening. Failure to diagnose breast cancer is the #1 malpractice claim in the U.S.

Review common clinical cases in breast disease. Breast Pain Breast Mass Nipple Discharge Abnormal Mammogram Result Discuss evidence-based evaluation and management strategies.

COMMON BREAST CASES Breast Pain Breast Mass Nipple Discharge Abnormal Screening Mammogram Breast Inflammation EVALUATION TOOLS Risk Assessment Physical Exam Breast Imaging Diagnostic Procedures

M.J. is a 35 y/o woman, G2P2, who presents with worsening bilateral breast pain. Pain becomes noticeable during the week prior to her menses and lasts for about 10 days. Has been present for several years, but worse over the past 6-9 months.

Does this patient have breast cancer? A. High likelihood B. Intermediate C. Low likelihood

The goal of risk assessment is to characterize patient given clinical scenario as low, intermediate, or high risk for breast cancer. Alternatively: Average age-based risk High risk

AGE 1 in 2000 women in their 20s. 1 in 25 women in their 70s.

Reproductive Factors Elevated risk associated with: Menarche: age<12 Menopause: age >55 Age of first birth 30 Nulliparity Breastfeeding < 2 months Hormone therapy after menopause?

Family History 1 st, 2 nd, 3 rd degree relatives with breast or ovarian cancer, others? Age at diagnosis of affected relatives

FH that warrants genetics referral: 2+ breast/ovarian/peritoneal CA in close relatives from the same side of the family (1 st, 2 nd, 3 rd degree) Early onset breast cancer (< 45 yrs) 2+ cancers in the same individual Known familial mutation Male breast cancer Epithelial ovarian cancer? NCCN 2009

Prior breast biopsies Non-proliferative no increased risk Proliferative slight increased risk Proliferative with atypia--adh, ALH >20% lifetime risk Lobular carcinoma in situ >20% lifetime risk History of therapeutic thoracic radiation

Relative Risk of Breast Cancer with Different Breast Lesions Breast cancer will often occur many years later and in a different location than the original lesion.

Gail Model http://www.cancer.gov/bcrisktool

Risk Assessment Age: 35 Reproductive Factors G2P2, first birth age 29 Breast fed x 2 children, 6 mo each Menarche age 11 Family History Mom: breast CA age 44 No prior breast biopsies No personal cancer history

How to Examine the Breasts: Visualize breasts for skin changes, symmetry. Palpate chest wall, breasts, and axillae. Assess for nipple discharge. Seated and supine positions. Consistent pattern. (Radial spokes, concentric circles, vertical strips) Boundaries. Time, time, time.

Position of Patient and Direction of Palpation for the Clinical Breast Examination Barton, M. B. et al. JAMA 1999;282:1270-1280. Copyright restrictions may apply.

Palpation Technique Barton, M. B. et al. JAMA 1999;282:1270-1280. Copyright restrictions may apply.

Levels of Pressure for Palpation of Breast Tissue Shown in a Cross-Sectional View of the Right Breast Barton, M. B. et al. JAMA 1999;282:1270-1280. Copyright restrictions may apply.

Physical Exam Doughy irregular breasts bilaterally, without discrete masses. Breast Imaging?

Breast Imaging Not indicated if bilateral pain without abnormalities on physical exam. Screening imaging for appropriate women. Diagnostic imaging directed by physical exam findings.

2/3 CYCLIC 1/3 NON-CYCLIC Hormonally mediated breast changes Fibrocystic changes Large pendulous breasts Breast cancer Mastalgia was the only symptom in 8% of cases. Caffeine, tobacco? Hormone therapy Duct ectasia Inflammatory Extramammary Chest wall pain Spinal/paraspinal disorders

Cyclic, bilateral breast pain Normal physical exam Is it interfering with her life? Does she desire treatment?

No treatment required Therapeutic options: Supportive garments NSAIDs (oral or topical) Low fat diet (<10%) Evening primrose oil (500 mg tid) Evaluate hormonal therapies Tamoxifen, danazol, bromocriptine Consider referral to genetic counselor.

K.M. is a 40 y/o G0 who presents due to finding a lump in her right breast while showering. Slight tenderness in the area. No history of breast masses. Was told she had fibrocystic breasts in the past.

Risk Assessment Age: 40 Reproductive Factors G0 Menarche age 11 Regular menses Family History Aunt breast cancer age 68 No prior breast biopsies No personal cancer history

Physical Exam Right Breast: Soft, smooth, mobile mass, ~3 cm in size, at the 10:00 position, 2 cm from areolar edge No nipple discharge, adenopathy No skin changes Left Breast: No dominant or concerning masses, no discharge

Does this patient have breast cancer? A. High likelihood B. Intermediate C. Low likelihood Differential?

Mammography Only modality used for routine screening. Modality of choice in women 30 with breast complaints. Detects calcifications and differences in density.

Ultrasound: Used as an adjunct to mammography. Best 1 st imaging study in women <30 with breast complaints. Differentiate between cystic and solid lesions.

MRI Used as a screening modality in high risk women (>20% lifetime risk). More false positives. Not generally appropriate for evaluation of routine complaints.

BI-RADS Classification: 0: Incomplete, needs more imaging 1: Negative 2: Benign findings 3: Probably benign ( 2% likelihood) Repeat imaging in 6 months x 1-2 yrs. Clinical suspicion. 4: Suspicious abnormality (3-94% likelihood) Consider biopsy 5: Highly suspicious ( 95% likelihood) Biopsy indicated 6: Biopsy proven malignancy

Order diagnostic mammogram +/- U/S Requisition should include clinical findings.

Breast Imaging Results: Mammogram: 3 cm mass in UOQ right breast Ultrasound: Simple cyst, 3 cm, correlates with mammographic mass Result: BI-RADS 2 benign finding

Diagnosis: Simple Breast Cyst Imaging and exam consistent! BI-RADS 2 cytology/histology not required

Management: Patient reassurance Cyst aspiration for patient comfort Fluid may be discarded Alternatively, observation. Will likely fluctuate over time.

M.G. is a 30 y/o woman, G1P1, who felt a lump in her right breast about 3 months ago. Not tender or painful. She thought it might go away, but it has not even seems a little bigger. No prior breast problems.

Risk Assessment Age: 30 Reproductive Factors G1P1, first birth at age 25 Menarche age 13 Regular menses on OCPs Family History Maternal Aunt breast cancer age 40 Maternal GM breast cancer age 61 No prior breast biopsies No personal cancer history

Physical Exam Right Breast: Firm, mobile mass, ~2-3 cm in size, at the 7:00 position, 1 cm from areolar edge No nipple discharge, adenopathy No skin changes Left Breast: No dominant or concerning masses, no discharge

Does this patient have breast cancer? A. High likelihood B. Intermediate C. Low likelihood Workup?

Breast Imaging Results: Ultrasound: Solid, well circumscribed mass, 2.5 cm, in area of palpable finding, c/w probable fibroadenoma Mammogram Well circumscribed mass Result: BI-RADS 4-- Suspicious finding

Is more evaluation required? A. Yes B. No C. Not sure

Fine Needle Aspiration Core Needle Biopsy Excisional Biopsy with or without wire localization

Fine needle aspiration Performed with a 22-24 gauge needle. May aspirate with syringe. Suspend cells in cytologic fluid (like liquidbased pap). Cytopathologist with expertise in breast cytology needed! Preferred for young, low risk women.

Triple diagnosis Using exam, imaging, and FNA: 0.7% with cancer if all three suggest benign disease 99.4% with cancer if all three suggest malignancy. If there is discordance between the three steps, open biopsy or core needle biopsy should be done.

Core needle biopsy Performed with a 14-18 gauge needle, generally using U/S or stereotactic mammography. May be performed with palpation. Histologic specimen obtained. Correlates with open biopsy 94% of the time, with less cost and better cosmetic result. Gold standard for histologic diagnosis.

Excisional Biopsy When core biopsy is non-diagnostic. When image-guided core biopsy is not possible due to location of lesion, imaging characteristics, patient characteristics. When mass does not have an imaging correlate. When high risk lesion identified on core biopsy ADH, ALH, LCIS, radial scar Wire localization allows for excision of nonpalpable imaging abnormalities.

Image-guided Core Needle Biopsy performed. Pathology: Benign fibroadenoma, no atypia Treatment?

Patient reassured by benign diagnosis. Options: Follow conservatively with exam for changes. Remove lesion >2 cm or for patient desire. Fibroadenomas are the most common solid masses identified in young women. Occur in 10-20% of women. Multiple fibroadenomas in 15-20% of cases.

S. K. is a 50 y/o woman who noticed staining of her bra with bloody fluid. On her self-exam, she was able to express bloody fluid from her left nipple. No pain or tenderness. No masses or other findings.

Risk Assessment Age: 50 Reproductive Factors G3P2, first birth at age 32 Menarche age 11 Family History No family history of cancer Prior breast biopsies Excisional bx age 30--fibroadenoma No personal cancer history

Physical Exam: Left Breast: No dominant or concerning masses No skin changes or adenopathy Expressed serosanguineous discharge from left nipple, single duct Right Breast: No dominant or concerning masses No skin changes, adenopathy, or discharge.

Blood malignancy vs papilloma Purulent infection Milky after childbearing up to one year+ hypothyroidism, prolactinomas medications: OCPs, tricyclic antidepressants, dopamine antagonists Grey, brown, green, sticky Duct ectasia. Common 5 th decade, with nipple tenderness and pain.

Spontaneous, bloody, unilateral, from one duct = more likely cancer Non-spontaneous, non-bloody, bilateral = less likely cancer

Does this patient have breast cancer? A. High likelihood B. Intermediate C. Low likelihood

Breast Imaging: Diagnostic mammogram + ultrasound Requisition to describe physical findings

Breast Imaging Results: Mammography + U/S No abnormalities identified Result: BI-RADS 1 Negative Now what?

Is more evaluation required? A: Yes B. No C. Not sure

Always pursue diagnostic test when clinical assessment does not correlate with imaging results.

Ductography Affected duct cannulated and injected with dye. Mammogram to identify, locate filling defect. Subareolar duct excision Affected duct cannulated in the OR and removed to approximately 4-5 cm beneath nipple. This is a necessary diagnostic step with suspicious discharge.

Pathology results: Benign intraductal papilloma. Routine clinical follow up. Even women with single, benign papilloma may be at increased future risk of breast cancer. Screening consideration.

Apply assessment tools to evaluation of breast complaints. Risk Assessment Physical Exam Breast Imaging Diagnostic Procedures Compare clinical assessment with imaging and diagnostic results. If above do not correlate, consider whether further workup is necessary. When in doubt, close follow up is appropriate.